Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccines, Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00928785
What this trial is testing

Study Comparing a Tdap-IPV Combined Vaccine With a Tetanus Monovalent Vaccine in Healthy Adults

Who this might be right for
Healthy
Sanofi Pasteur, a Sanofi Company 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06739226
What this trial is testing

Combination Immunotherapy Targeting Melanoma

Who this might be right for
Melanoma
Shenzhen Geno-Immune Medical Institute 30
Large-scale testing (Phase 3)Study completedNCT01986335
What this trial is testing

Protectivity and Safety of DTP/HB/Hib (Bio Farma) Vaccines in Infants, Batch Consistency, Multi Center Trial

Who this might be right for
Healthy
PT Bio Farma 600
Large-scale testing (Phase 3)UnknownNCT02503150
What this trial is testing

Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Second Military Medical University 480
Testing effectiveness (Phase 2)Study completedNCT00084383
What this trial is testing

Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Testing effectiveness (Phase 2)Study completedNCT04661579
What this trial is testing

Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial Therapy

Who this might be right for
Plasmodium Falciparum
PATH 620
Testing effectiveness (Phase 2)Active Not RecruitingNCT04397003
What this trial is testing

Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Washington University School of Medicine 6
Testing effectiveness (Phase 2)Study completedNCT00050323
What this trial is testing

Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney Cancer

Who this might be right for
Carcinoma, Renal Cell
Genzyme, a Sanofi Company 30
Early research (Phase 1)Ended earlyNCT05262673
What this trial is testing

NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia
Shenzhen Geno-Immune Medical Institute 10
Testing effectiveness (Phase 2)Study completedNCT01302496
What this trial is testing

Autologous TriMix-DC Therapeutic Vaccine in Combination With Ipilimumab in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Who this might be right for
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Bart Neyns 39
Early research (Phase 1)Study completedNCT00083603
What this trial is testing

Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 150
Testing effectiveness (Phase 2)Study completedNCT00805389
What this trial is testing

Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine

Who this might be right for
Hepatitis B
GlaxoSmithKline 713
Large-scale testing (Phase 3)Study completedNCT06817187
What this trial is testing

Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine

Who this might be right for
Streptococcus Pneumoniae Infections
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1,110
Testing effectiveness (Phase 2)Study completedNCT02439450
What this trial is testing

Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Heat Biologics 121
Testing effectiveness (Phase 2)Active Not RecruitingNCT01088789
What this trial is testing

Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 71
Early research (Phase 1)UnknownNCT02188810
What this trial is testing

Safety and Reactogenicity of a PAL Combined With Seasonal Flu Vaccine in Healthy Adults

Who this might be right for
Flu
Folia Biotech Inc. 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT06223568
What this trial is testing

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckOropharynxHuman Papillomavirus Viruses+2 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)WithdrawnNCT00637117
What this trial is testing

Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma.

Who this might be right for
Lymphoma
Baylor Research Institute
Testing effectiveness (Phase 2)Ended earlyNCT00045617
What this trial is testing

S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 9
Early research (Phase 1)Study completedNCT00141024
What this trial is testing

Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 84
Next Page